Chemoinformaics analysis of EPISTEPHAMIERSINE
Molecular Weight | 389.448 | nRot | 4 |
Heavy Atom Molecular Weight | 362.232 | nRig | 23 |
Exact Molecular Weight | 389.184 | nRing | 5 |
Solubility: LogS | -2.798 | nHRing | 2 |
Solubility: LogP | 1.577 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
nHA | 7 | APOL | 58.9854 |
nHD | 0 | BPOL | 38.3446 |
QED | 0.778 |
Synth | 5.98 |
Natural Product Likeliness | 2.642 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.018 |
Pgp-sub | 0.172 |
HIA | 0.019 |
CACO-2 | -4.935 |
MDCK | 0.0000288 |
BBB | 0.995 |
PPB | 0.382726 |
VDSS | 1.458 |
FU | 0.471272 |
CYP1A2-inh | 0.013 |
CYP1A2-sub | 0.983 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.972 |
CYP2c9-inh | 0.018 |
CYP2c9-sub | 0.177 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.823 |
CYP3a4-inh | 0.055 |
CYP3a4-sub | 0.952 |
CL | 8.888 |
T12 | 0.194 |
hERG | 0.144 |
Ames | 0.744 |
ROA | 0.955 |
SkinSen | 0.132 |
Carcinogencity | 0.883 |
EI | 0.011 |
Respiratory | 0.904 |
NR-Aromatase | 0.857 |
Antiviral | Yes |
Prediction | 0.526688 |